http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_62b37d1b72bda9da02120a1f67297b8e
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Cruzalegui |
| name | Francisco Cruzalegui |
| given-name | Francisco |
| organization-name | Institut de Recherches Servier, 125 Chemin de Ronde, 78290 Croissy-sur-Seine, France Authors' Affiliations: 1Institut Curie, Centre de Recherche; 2AgroParisTech/INRA UMR MIA 518, Paris; 3Translational Research Department; 4Breast Cancer Biology Group; 5Laboratory of Preclinical Investigation; 6Tumor Biology Department, Institut Curie Hospital; 7INSERM U830; 8INSERM U900; 9Mines ParisTech, Fontainebleau; 10Departments of Biostatistics and 11Medical Oncology; 12Reverse Phase Protein Array Platform; 13Platform of Molecular Biology Facilities; and 14Oncology Research and Development Unit, Institut de Recherches SERVIER, Croissy-sur-Seine, France 1AstraZeneca Pharmaceuticals, Oncology iMed, Macclesfield, Cheshire, United Kingdom. Institute de Recherche Servier 50 Rue Carnot Suresnes 92150 France; Present address: Pierre Fabre R&D Centre 3 Av. Hubert Curien 31035 Toulouse Cedex 1 France Institut de Recherches Servier, 125 chemin de ronde, Croissy sur Seine 78290 France Institut de Recherches Servier, 125 Chemin de Ronde, Croissy-sur-Seine 78290, France Institut de Recherches Servier, 125 chemin de ronde, F-78290, Croissy sur Seine, France Translational Science, Oncology, IMED Biotech Unit, AstraZeneca, Cambridge, UK; Current address: Pierre Fabre R&D Centre, Toulouse, France 4Discovery Sciences, AstraZeneca, Cambridge, United Kingdom. Oncology Research and Development Unit, Institut de Recherches SERVIER, Croissy-Sur-Seine, France Instituto de Medicina Tropical “Alexander von Humboldt,”, Innovative Medicines and Early Development (IMED) Oncology AstraZeneca, Li Ka Shing Centre, Cambridge, United Kingdom; 5Translational Sciences, Oncology, IMED Biotech Unit, AstraZeneca, Cambridge, United Kingdom. |
Incoming Links
Total number of triples: 39.